3M Company (NYSE:MMM) delivered a solid start to 2026, reporting adjusted earnings that exceeded Wall Street expectations and reaffirming its financial outlook for the year.
The industrial and consumer giant's results reflect a successful push into higher-margin categories and effective cost management, helping to offset broader economic pressures and the impact of its ongoing business restructuring.
For the first quarter ended March 31, 2026, the St. Paul, Minnesota-based conglomerate reported GAAP sales of $6 billion, a 1.3% increase year-over-year.
On an adjusted basis—which provides a clearer view of core performance following the spinoff of its healthcare unit—sales grew 3.9%, supported by a 1.2% rise in adjusted organic growth and a significant 2.8% tailwind from favorable currency translation.
Profitability remained a key highlight as the company’s "value creation framework" drove margin expansion.
Adjusted earnings per share (EPS) reached $2.14, a 14% increase from the prior year and well above the consensus analyst estimate of $2.
However, GAAP EPS fell 40% to $1.23, primarily due to one-time transformation costs and fluctuations in the value of the company's remaining stake in Solventum.
Despite these items, the GAAP operating margin improved to 23.2%, up 230 basis points from 2025.
Cash flow generation supported substantial capital returns during the quarter. 3M generated $0.6 billion in cash from operations and reported adjusted free cash flow of $0.5 billion. The company returned $2.4 billion to shareholders through a combination of dividends and aggressive share repurchases, signaling management's confidence in the firm’s long-term value.
Looking ahead, 3M reiterated its full-year 2026 guidance. The company continues to expect adjusted total sales growth of approximately 4% and adjusted EPS in the range of $8.50 to $8.70. Management also remains committed to achieving an adjusted operating margin expansion of 70 to 80 basis points for the full fiscal year.